- Welcome to GenetiX is a clinical-stage biotechnology company
Advancing the Future of Cell and Gene Therapy
Purpose-Driven Innovation
To develop scalable, automated cell and gene therapies that deliver safe and effective treatments worldwide.
From Breakthrough Research to Real-World Impact
Next-Generation CAR-T Therapy
Intelligent Therapeutic Cells
To transform healthcare by making advanced therapies accessible and clinically meaningful for patients everywhere.
- About us
Advancing Innovation at the Heart of Cambridge
GenetiX was founded in Cambridge, United Kingdom, with a mission to redefine the development and delivery of advanced biologics, cell therapies, and gene therapies.
Built on scientific foundations shaped in the laboratory of a Nobel Prize–winning scientist, and guided by a legacy of creating transformative biotechnology companies, we are committed to delivering innovation, quality, and clinical excellence to patients worldwide.
Located at the Cambridge Biomedical Campus, alongside global leaders such as AstraZeneca, we operate within one of the world’s most dynamic life sciences ecosystems. By integrating cutting-edge engineering, advanced manufacturing, and deep scientific expertise, Cambridge GenetiX develops accessible, scalable, and clinically meaningful therapies that bridge breakthrough science with real-world patient needs.
Dr. Tanvir Hasan
Chief Medical Officer
- biologics, cell therapies, and gene therapies
Built on Scientific Excellence
A Growing Portfolio of Advanced Therapies
Our pipeline spans cell therapies, gene therapies, biologics, and enabling technologies, each advancing through defined clinical development phases supported by data-driven design and automation.
Next-Generation CAR-T Therapy
GX-01 (Ariflex) is our lead clinical candidate, engineered with a fully humanized Anti-CD19 scFv and second-generation CAR architecture to deliver superior safety and efficacy.
Gene Therapy Development
- Advanced cell and gene therapy development from discovery through clinical readiness
- Precision CAR-T engineering focused on safety, efficacy, and durability
- Automated, scalable manufacturing solutions for clinical and commercial production
- Services & Solutions
End-to-End Solutions for Advanced Therapeutic Development
Cell & Gene Therapy Development
End-to-end development of engineered cell and gene therapies from discovery to clinical readiness.
GMP-Grade Reagents & Kits
High-quality clinical-grade reagents, per-patient CAR-T kits, and validation tools.
Biologics Development
Design and scalable manufacturing of clinically relevant biologic products.
Automated CAR-T Manufacturing
Scalable, standardized, and automated CAR-T production systems designed for clinical compliance.
- Ready to Shape the Future of Therapy?